WHO Grade 3 Glioma — Trials

WHO Grade 3 Glioma — Trials · CancerIndex

Clinical trials

Registered studies

258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 32
Ph III recruiting: 2
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06333899	Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion	recruiting	Early Phase 1	15	Nationwide Children's HospitalOTHER	6	Jun 29, 2026	clinicaltrials
NCT04135807	Implantable Microdevice In Primary Brain Tumors	recruiting	Early Phase 1	12	Oliver JonasOTHER	1	Jul 23, 2025	clinicaltrials
NCT03893487